speb/financial-data huggingface dataset:
Financial ratios for BIIB — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 152.92
Shares outstanding: 147637117
Market cap (USD): 22576667931.64
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIIB — quarterly report dated 2025-03-31
Total revenue: 2431000000
Gross profit: 1801700000
Operating income: 625200000
Net income: 240500000
Capital expenditures: 37100000
Operating cash flow: 259300000
Depreciation & amortization: 183200000
Net tangible assets: 917000000
Owner earnings: 386600000
Return on net tangible assets (%): 42.159214830970555
Capex to operating income (%): 5.9341010876519515
Buffett classification: The Great
Stock price: 136.84
P/E ratio: 21.000689283035342
Shares outstanding: 147637117
Book value: 16978700000
P/B ratio: 1.1898827996419044
Market cap (USD): 20202663090.28
Debt to equity: 0.38997096361912276
Current ratio: 1.4395741307056291
Quick ratio: 1.0103258202136898
Effective tax rate (%): 22.718508997429307
Interest coverage ratio: 10.42
COGS to revenue (%): 25.88646647470177
R&D to revenue (%): 17.856849033319623
SG&A to revenue (%): 23.549979432332375
Free cash flow (dilution-adjusted): 131200000
Buyback yield (%): 0
Retained earnings: 19500300000
Inventory turnover: 0.2767491974141343
Receivables turnover: 1.2176308539944904
Capitalized R&D asset: 434100000
ROCI (R&D-adjusted, %): 3.947379778850055
FCF margin (%): 5.396955985191279
Rule of 40 score: 5.396955985191279
Financial ratios for BIIB — quarterly report dated 2025-06-30
Total revenue: 2645500000
Gross profit: 2040500000
Operating income: 851800000
Net income: 634800000
Capital expenditures: 26600000
Operating cash flow: 160900000
Depreciation & amortization: 194300000
Net tangible assets: 1673400000
Owner earnings: 802500000
Return on net tangible assets (%): 47.95625672283973
Capex to operating income (%): 3.1227987790561165
Buffett classification: The Great
Stock price: 125.59
P/E ratio: 21.18330346627442
Shares outstanding: 147637117
Book value: 17634000000
P/B ratio: 1.0514770060128162
Market cap (USD): 18541745524.03
Debt to equity: 0.37397073834637634
Current ratio: 2.5026541445487953
Quick ratio: 1.7882966359895718
Effective tax rate (%): 14.677419354838708
Interest coverage ratio: 11.732782369146005
COGS to revenue (%): 22.86902286902287
R&D to revenue (%): 15.082215082215084
SG&A to revenue (%): 22.067662067662067
Free cash flow (dilution-adjusted): 59400000
Buyback yield (%): 0
Retained earnings: 20135100000
Inventory turnover: 0.2660159169854461
Receivables turnover: 1.2694337811900192
Capitalized R&D asset: 689847000
ROCI (R&D-adjusted, %): 3.7663993288215245
Rosenberg metric: 0.5501036627505184
FCF margin (%): 2.2453222453222454
Revenue growth (%): 8.823529411764707
Rule of 40 score: 11.068851657086952
Financial ratios for BIIB — quarterly report dated 2025-09-30
Total revenue: 2534700000
Gross profit: 1860300000
Operating income: 606500000
Net income: 466500000
Capital expenditures: 46200000
Operating cash flow: 1272500000
Depreciation & amortization: 202200000
Net tangible assets: 2384900000
Owner earnings: 622500000
Return on net tangible assets (%): 26.10172334269781
Capex to operating income (%): 7.617477328936522
Buffett classification: The Great
Stock price: 140.08
P/E ratio: 15.412883700521688
Shares outstanding: 147637117
Book value: 18207500000
P/B ratio: 1.1358510146565977
Market cap (USD): 20681007349.36
Debt to equity: 0.36194425374159
Current ratio: 2.71629179331307
Quick ratio: 2.044741641337386
Effective tax rate (%): 16.292840480890007
Interest coverage ratio: 8.998516320474778
COGS to revenue (%): 26.606699017635222
R&D to revenue (%): 17.2051919359293
SG&A to revenue (%): 23.46628792362015
Free cash flow (dilution-adjusted): 1145700000
Buyback yield (%): 0
Retained earnings: 20601600000
Inventory turnover: 0.30524124196614466
Receivables turnover: 1.3701081081081081
Capitalized R&D asset: 846683000
ROCI (R&D-adjusted, %): 2.31478514899309
Rosenberg metric: -0.45162907268170427
FCF margin (%): 45.20061545745059
Revenue growth (%): -4.188244188244188
Rule of 40 score: 41.0123712692064
Financial ratios for BIIB — annual report dated 2025-12-31
Total revenue: 9890600000
Gross profit: 7486400000
Operating income: 2469000000
Net income: 1292900000
Capital expenditures: 153800000
Operating cash flow: 2204600000
Depreciation & amortization: 779900000
Net tangible assets: 2587200000
Owner earnings: 1919000000
Return on net tangible assets (%): 74.17285095856523
Capex to operating income (%): 6.229242608343459
Buffett classification: The Great
Stock price: 175.99
P/E ratio: 20.09641598022276
Shares outstanding: 147637117
Book value: 18256800000
P/B ratio: 1.423176910566474
Market cap (USD): 25982656220.83
Debt to equity: 0.3602602865781517
Current ratio: 2.67931569833403
Quick ratio: 2.0320057323699765
Effective tax rate (%): 16.93543205910697
Interest coverage ratio: 9.229906542056074
COGS to revenue (%): 24.3079287404202
R&D to revenue (%): 17.982731077993247
SG&A to revenue (%): 24.605180676602025
Free cash flow (dilution-adjusted): 1678400000
Buyback yield (%): 0
Retained earnings: 20552700000
Inventory turnover: 1.108897191088972
Receivables turnover: 5.297589716122121
Capitalized R&D asset: 3912383000
ROCI (R&D-adjusted, %): 7.26439874993013
Rosenberg metric: 0.06105135585517346
FCF margin (%): 16.969647948557213
Revenue growth (%): 2.21891503632737
Rule of 40 score: 19.188562984884584
Financial ratios for BIIB — quarterly report dated 2025-12-31
Total revenue: 2279400000
Gross profit: 1783900000
Operating income: 385500000
Net income: -48900000
Capital expenditures: 43900000
Operating cash flow: 511900000
Depreciation & amortization: 200200000
Net tangible assets: 2587200000
Owner earnings: 107400000
Capex to operating income (%): 11.38780804150454
Buffett classification: The Great
Stock price: 175.99
P/E ratio: 20.09641598022276
Shares outstanding: 147637117
Book value: 18256800000
P/B ratio: 1.423176910566474
Market cap (USD): 25982656220.83
Debt to equity: 0.3602602865781517
Current ratio: 2.67931569833403
Quick ratio: 2.0320057323699765
Interest coverage ratio: 5.711111111111111
COGS to revenue (%): 21.738176713170134
R&D to revenue (%): 22.347986312187416
SG&A to revenue (%): 29.942090023690444
Free cash flow (dilution-adjusted): 342100000
Buyback yield (%): 0
Retained earnings: 20552700000
Inventory turnover: 0.22854111895207785
Receivables turnover: 1.2208891269416176
Capitalized R&D asset: 933257000
ROCI (R&D-adjusted, %): 1.6531378145703115
Rosenberg metric: -0.17518917679431323
FCF margin (%): 15.00833552689304
Revenue growth (%): -10.072197893241803
Rule of 40 score: 4.936137633651237
Financial ratios for CCSI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 57.87
Shares outstanding: 18397950
Market cap (USD): 1064689366.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCSI — annual report dated 2022-12-31
Total revenue: 362422000
Gross profit: 300471000
Operating income: 151918000
Net income: 72714000
Capital expenditures: 30045000
Operating cash flow: 83149000
Depreciation & amortization: 15302000
Net tangible assets: -651002000
Owner earnings: 57971000
Return on net tangible assets (%): -8.904888157025631
Capex to operating income (%): 19.777116602377596
Buffett classification: The Great
Stock price: 53.76
P/E ratio: 13.60224705008664
Shares outstanding: 18397950
Book value: -255261000
Market cap (USD): 989073792
Debt to equity: -3.1753185954767864
Current ratio: 1.9142480581026893
Quick ratio: 1.9142480581026893
Effective tax rate (%): 26.486912741500106
Interest coverage ratio: 2.954281158236587
COGS to revenue (%): 17.093609107614878
R&D to revenue (%): 2.7641809823906938
SG&A to revenue (%): 38.2247766415946
Free cash flow (dilution-adjusted): 32049000
Buyback yield (%): 0.7679912319423786
Retained earnings: -250408000
Receivables turnover: 12.930250811659352
Capitalized R&D asset: 10018000
ROCI (R&D-adjusted, %): 27.69787837243892
FCF margin (%): 8.843006219269249
Rule of 40 score: 8.843006219269249
Financial ratios for CCSI — annual report dated 2023-12-31
Total revenue: 362562000
Gross profit: 294243000
Operating income: 147229000
Net income: 77295000
Capital expenditures: 36461000
Operating cash flow: 114113000
Depreciation & amortization: 17421000
Net tangible assets: -569934000
Owner earnings: 58255000
Return on net tangible assets (%): -10.221358964371314
Capex to operating income (%): 24.764822147810552
Buffett classification: The Great
Stock price: 26.21
P/E ratio: 6.2385700174655545
Shares outstanding: 18397950
Book value: -176122000
Market cap (USD): 482210269.5
Debt to equity: -4.254039813311228
Current ratio: 1.7545668497142217
Quick ratio: 1.7545668497142217
Effective tax rate (%): 25.07560777015238
Interest coverage ratio: 3.2452884255075274
COGS to revenue (%): 18.84339781885581
R&D to revenue (%): 2.1312216944963898
SG&A to revenue (%): 38.417429294851644
Free cash flow (dilution-adjusted): 59489000
Buyback yield (%): 4.86986725196652
Retained earnings: -173113000
Receivables turnover: 13.763647407182447
Capitalized R&D asset: 14439060
ROCI (R&D-adjusted, %): 25.24791801786336
Rosenberg metric: -0.6216809742463566
FCF margin (%): 16.407952295055743
Revenue growth (%): 0.03862900155067849
Rule of 40 score: 16.44658129660642
Financial ratios for CCSI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.55
Shares outstanding: 18397950
Market cap (USD): 433271722.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCSI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.86
Shares outstanding: 18397950
Market cap (USD): 438975087
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCSI — annual report dated 2024-12-31
Total revenue: 350382000
Gross profit: 280694000
Operating income: 149400000
Net income: 89435000
Capital expenditures: 33440000
Operating cash flow: 121747000
Depreciation & amortization: 20516000
Net tangible assets: -465712000
Owner earnings: 76511000
Return on net tangible assets (%): -16.42882296354829
Capex to operating income (%): 22.382864792503344
Buffett classification: The Great
Stock price: 23.86
P/E ratio: 4.908314272935652
Shares outstanding: 18397950
Book value: -79463000
Market cap (USD): 438975087
Debt to equity: -7.640662950052225
Current ratio: 0.9396552811085473
Quick ratio: 0.9396552811085473
Effective tax rate (%): 26.83954353961307
Interest coverage ratio: 4.396833338238324
COGS to revenue (%): 19.88914955676947
R&D to revenue (%): 2.1927496275493605
SG&A to revenue (%): 35.27892414564675
Free cash flow (dilution-adjusted): 71543000
Buyback yield (%): 0.23486526468869975
Retained earnings: -83678000
Receivables turnover: 14.05970867942699
Capitalized R&D asset: 16166030
ROCI (R&D-adjusted, %): 27.56800624231956
Rosenberg metric: -1.7534618868901255
FCF margin (%): 20.41857173028295
Revenue growth (%): -3.3594254224105122
Rule of 40 score: 17.059146307872435
Financial ratios for CCSI — quarterly report dated 2025-03-31
Total revenue: 87138000
Gross profit: 69068000
Operating income: 37497000
Net income: 21152000
Capital expenditures: 7196000
Operating cash flow: 40943000
Depreciation & amortization: 5178000
Net tangible assets: -437329000
Owner earnings: 19134000
Return on net tangible assets (%): -4.375195790811952
Capex to operating income (%): 19.19086860282156
Buffett classification: The Great
Stock price: 23.08
P/E ratio: 5.018729741868381
Shares outstanding: 18397950
Book value: -49358000
Market cap (USD): 424624685.99999994
Debt to equity: -12.105352729040884
Current ratio: 1.2469970686481695
Quick ratio: 1.2469970686481695
Effective tax rate (%): 24.118385650224212
Interest coverage ratio: 4.177473262032086
COGS to revenue (%): 20.73722141889876
R&D to revenue (%): 1.964699671784985
SG&A to revenue (%): 34.266336156441504
Free cash flow (dilution-adjusted): 29483000
Buyback yield (%): 0.008007070978440478
Retained earnings: -62526000
Receivables turnover: 3.262129380053908
Capitalized R&D asset: 1712000
ROCI (R&D-adjusted, %): 6.924258770090595
FCF margin (%): 33.83483669581583
Rule of 40 score: 33.83483669581583
Financial ratios for CCSI — quarterly report dated 2025-06-30
Total revenue: 87721000
Gross profit: 70097000
Operating income: 39049000
Net income: 20781000
Capital expenditures: 7954000
Operating cash flow: 28299000
Depreciation & amortization: 4571000
Net tangible assets: -419243000
Owner earnings: 17398000
Return on net tangible assets (%): -4.149860582049074
Capex to operating income (%): 20.369279623037723
Buffett classification: The Great
Stock price: 23.06
P/E ratio: 10.117490449049674
Shares outstanding: 18397950
Book value: -26479000
Market cap (USD): 424256727
Debt to equity: -22.33279202386797
Current ratio: 1.4922500645827952
Quick ratio: 1.4922500645827952
Effective tax rate (%): 27.196608744394617
Interest coverage ratio: 4.502363657327337
COGS to revenue (%): 20.090970235177437
R&D to revenue (%): 1.9881214304442494
SG&A to revenue (%): 33.40591192530865
Free cash flow (dilution-adjusted): 16138000
Buyback yield (%): 2.9015450354897965
Retained earnings: -41745000
Receivables turnover: 3.5330057593942565
Capitalized R&D asset: 2891040
ROCI (R&D-adjusted, %): 6.805636875485259
Rosenberg metric: 0.6010514018691588
FCF margin (%): 18.39696309891588
Revenue growth (%): 0.6690536849594896
Rule of 40 score: 19.06601678387537
Financial ratios for CCSI — quarterly report dated 2025-09-30
Total revenue: 87767000
Gross profit: 70247000
Operating income: 37930000
Net income: 22091000
Capital expenditures: 7185000
Operating cash flow: 51626000
Depreciation & amortization: 4519000
Net tangible assets: -394751000
Owner earnings: 19425000
Return on net tangible assets (%): -4.920823506463568
Capex to operating income (%): 18.94278934880042
Buffett classification: The Great
Stock price: 29.37
P/E ratio: 8.439769328689241
Shares outstanding: 18397950
Book value: -2633000
Market cap (USD): 540347791.5
Debt to equity: -224.6517280668439
Current ratio: 1.8399431801876776
Quick ratio: 1.8399431801876776
Effective tax rate (%): 26.316667222574296
Interest coverage ratio: 4.292666364870982
COGS to revenue (%): 19.961944694475147
R&D to revenue (%): 2.221791789624802
SG&A to revenue (%): 34.59956475668531
Free cash flow (dilution-adjusted): 40475000
Buyback yield (%): 0.4981976501702793
Retained earnings: -19654000
Receivables turnover: 3.630486039296794
Capitalized R&D asset: 3683440
ROCI (R&D-adjusted, %): 6.252920536576055
Rosenberg metric: 0.0860091743119266
FCF margin (%): 46.11642188977634
Revenue growth (%): 0.05243898268373593
Rule of 40 score: 46.16886087246008
Financial ratios for CCSI — annual report dated 2025-12-31
Total revenue: 349696000
Gross profit: 279095000
Operating income: 150239000
Net income: 84527000
Capital expenditures: 30233000
Operating cash flow: 136086000
Depreciation & amortization: 18733000
Net tangible assets: -377927000
Owner earnings: 73027000
Return on net tangible assets (%): -19.323043868260275
Capex to operating income (%): 20.123270256058678
Buffett classification: The Great
Stock price: 21.82
P/E ratio: 4.74929039241899
Shares outstanding: 18397950
Book value: 13773000
P/B ratio: 29.147118928338056
Market cap (USD): 401443269
Debt to equity: 41.43607057285994
Current ratio: 1.7876499130275565
Quick ratio: 1.7876499130275565
Effective tax rate (%): 25.859361980194546
Interest coverage ratio: 4.228749155595587
COGS to revenue (%): 20.18925009150805
R&D to revenue (%): 2.1344253294289897
SG&A to revenue (%): 34.71357979502196
Free cash flow (dilution-adjusted): 88160000
Buyback yield (%): 5.734309621716437
Retained earnings: 849000
Receivables turnover: 14.763826733091278
Capitalized R&D asset: 15161520
ROCI (R&D-adjusted, %): 24.46509771400292
Rosenberg metric: -0.20812182741116753
FCF margin (%): 25.210468521229867
Revenue growth (%): -0.19578631322385281
Rule of 40 score: 25.014682208006015
Financial ratios for CCSI — quarterly report dated 2025-12-31
Total revenue: 87070000
Gross profit: 69683000
Operating income: 35763000
Net income: 20503000
Capital expenditures: 7898000
Operating cash flow: 15218000
Depreciation & amortization: 4465000
Net tangible assets: -377927000
Owner earnings: 17070000
Return on net tangible assets (%): -4.516745297372244
Capex to operating income (%): 22.084277046109108
Buffett classification: The Great
Stock price: 21.82
P/E ratio: 4.74929039241899
Shares outstanding: 18397950
Book value: 13773000
P/B ratio: 29.147118928338056
Market cap (USD): 401443269
Debt to equity: 41.43607057285994
Current ratio: 1.7876499130275565
Quick ratio: 1.7876499130275565
Effective tax rate (%): 25.73798399072766
Interest coverage ratio: 3.954771646577463
COGS to revenue (%): 19.96899046743999
R&D to revenue (%): 2.363615481796256
SG&A to revenue (%): 36.59354542322269
Free cash flow (dilution-adjusted): 2064000
Buyback yield (%): 1.9888239800079945
Retained earnings: 849000
Receivables turnover: 3.6760111458245377
Capitalized R&D asset: 3940020
ROCI (R&D-adjusted, %): 5.961914969900164
Rosenberg metric: -0.28923076923076924
FCF margin (%): 2.3705064890318135
Revenue growth (%): -0.7941481422402497
Rule of 40 score: 1.5763583467915638
Financial ratios for CCV.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.11278195488721804
Shares outstanding: 711522934
Market cap (USD): 80246947.44360901
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCV.AX — annual report dated 2022-06-30
Total revenue: 146351034.4827586
Gross profit: 112853793.10344829
Operating income: 2623448.275862069
Net income: 7708275.862068966
Capital expenditures: 964827.5862068966
Depreciation & amortization: 9384827.586206896
Net tangible assets: 129573793.10344829
Owner earnings: 16128275.862068968
Return on net tangible assets (%): 12.447174290246005
Capex to operating income (%): 36.777076761303896
Buffett classification: The Good
Stock price: 0.11724137931034484
P/E ratio: 10.822125684888611
Shares outstanding: 711522934
Book value: 217484137.9310345
P/B ratio: 0.383567882176108
Market cap (USD): 83419930.19310346
Debt to equity: 0.42232806514624927
Current ratio: 2.6830576925315115
Quick ratio: 2.4043830960999055
Effective tax rate (%): 27.351316217094574
Interest coverage ratio: 0.5451418744625968
COGS to revenue (%): 22.888284662761716
SG&A to revenue (%): 47.674226823556026
Free cash flow (dilution-adjusted): 4146206.896551724
Buyback yield (%): 0
Retained earnings: 39486896.551724136
Inventory turnover: 2.028524891413298
Receivables turnover: 1.4453881676633655
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9697476463735157
FCF margin (%): 2.833056090929226
Rule of 40 score: 2.833056090929226
Financial ratios for CCV.AX — annual report dated 2023-06-30
Total revenue: 173520529.80132452
Gross profit: 134516556.29139072
Operating income: 2005298.013245033
Net income: -64341059.602649
Capital expenditures: 1967549.6688741723
Depreciation & amortization: 8222516.556291391
Net tangible assets: 120974834.43708609
Owner earnings: -58086092.71523178
Return on net tangible assets (%): -48.01502145922746
Capex to operating income (%): 98.11756935270807
Buffett classification: The Gruesome
Stock price: 0.11920529801324503
Shares outstanding: 711522934
Book value: 136750993.37748346
P/B ratio: 0.6202317167569033
Market cap (USD): 84817303.39072847
Debt to equity: 0.9721008842871947
Current ratio: 1.9416437166772937
Quick ratio: 1.7619351250152624
Interest coverage ratio: 0.2815434681543468
COGS to revenue (%): 22.47801660967269
SG&A to revenue (%): 46.55975207620908
Free cash flow (dilution-adjusted): -10603973.509933775
Buyback yield (%): 0
Retained earnings: -35213245.033112586
Inventory turnover: 2.2230777941343
Receivables turnover: 1.411427555632168
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.025581970350249
FCF margin (%): -6.111077186126038
Revenue growth (%): 18.56460763300358
Rule of 40 score: 12.45353044687754
Financial ratios for CCV.AX — annual report dated 2024-06-30
Total revenue: 251428000
Gross profit: 187422666.66666666
Operating income: 31257333.333333332
Net income: 11598000
Capital expenditures: 3057333.3333333335
Depreciation & amortization: 10844000
Net tangible assets: 118830000
Owner earnings: 19384666.666666668
Return on net tangible assets (%): 16.31294005441948
Capex to operating income (%): 9.781171351789448
Buffett classification: The Great
Stock price: 0.12666666666666668
P/E ratio: 7.7708431028338225
Shares outstanding: 711522934
Book value: 140910666.66666666
P/B ratio: 0.6395984096779994
Market cap (USD): 90126238.30666667
Debt to equity: 1.0175430296263355
Current ratio: 1.7890233012328391
Quick ratio: 1.5767874236301613
Effective tax rate (%): 35.24047051816557
Interest coverage ratio: 2.8097321268052977
COGS to revenue (%): 25.456724522858764
SG&A to revenue (%): 40.183803448038134
Free cash flow (dilution-adjusted): 21328666.666666668
Buyback yield (%): 0
Retained earnings: -32236000
Inventory turnover: 2.9061629737256327
Receivables turnover: 2.036392892047019
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.543661071837358
FCF margin (%): 8.483011703814478
Revenue growth (%): 44.898128358573516
Rule of 40 score: 53.38114006238799
Financial ratios for CEQ.V — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 0.11811023622047244
Shares outstanding: 139751234
Market cap (USD): 16506051.259842519
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEQ.V — annual report dated 2022-12-31
Total revenue: 138116.17647058822
Gross profit: 131552.94117647057
Operating income: -957170.5882352941
Net income: -972900.7352941176
Capital expenditures: 1643061.0294117646
Operating cash flow: -573513.9705882353
Depreciation & amortization: 6563.235294117647
Net tangible assets: 2950210.2941176468
Owner earnings: -2609398.529411765
Return on net tangible assets (%): -88.44788232942518
Buffett classification: The Gruesome
Stock price: 0.14705882352941177
Shares outstanding: 139751234
Book value: 2950210.2941176468
P/B ratio: 6.966165123822181
Market cap (USD): 20551652.05882353
Debt to equity: 0.0401434493951827
Current ratio: 1.7859119026640882
Quick ratio: 1.7859119026640882
Interest coverage ratio: -205.58307012002527
COGS to revenue (%): 4.751967120603925
SG&A to revenue (%): 761.7569394904119
Free cash flow (dilution-adjusted): -2337540.4411764704
Buyback yield (%): 0
Retained earnings: -3323836.764705882
Receivables turnover: 1.1679361309216623
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -31.375206888049433
FCF margin (%): -1692.445085658919
Rule of 40 score: -1692.445085658919
Financial ratios for CEQ.V — annual report dated 2023-12-31
Total revenue: 80303.0303030303
Gross profit: 53030.303030303025
Operating income: -2431060.606060606
Net income: -2885606.0606060605
Capital expenditures: 0
Operating cash flow: -2043181.8181818181
Depreciation & amortization: 27272.727272727272
Net tangible assets: 765151.5151515151
Owner earnings: -2858333.3333333335
Return on net tangible assets (%): -373.56435643564356
Buffett classification: The Gruesome
Stock price: 0.09848484848484848
Shares outstanding: 139751234
Book value: 765151.5151515156
P/B ratio: 17.987782594059393
Market cap (USD): 13763379.106060605
Debt to equity: 0.13465346534653458
Current ratio: 1.0756089496307726
Quick ratio: 1.0756089496307726
Interest coverage ratio: -139.52173913043478
COGS to revenue (%): 33.9622641509434
SG&A to revenue (%): 2355.66037735849
Free cash flow (dilution-adjusted): -2273484.8484848486
Buyback yield (%): 0
Retained earnings: -6309848.484848484
Receivables turnover: 1.6562500000000002
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -286.77390527256483
FCF margin (%): -2831.1320754716985
Revenue growth (%): -41.85834537627039
Rule of 40 score: -2872.990420847969
Financial ratios for CEQ.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.07407407407407407
Shares outstanding: 139751234
Market cap (USD): 10351943.25925926
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEQ.V — annual report dated 2024-12-31
Total revenue: 20943356.643356644
Gross profit: 12434965.034965036
Operating income: -874125.8741258741
Net income: -6933566.433566434
Capital expenditures: 4180419.5804195805
Operating cash flow: -353846.1538461539
Depreciation & amortization: 3111188.8111888114
Net tangible assets: 584615.3846153846
Owner earnings: -8002797.202797203
Return on net tangible assets (%): -1368.8995215311004
Buffett classification: The Gruesome
Stock price: 0.04895104895104896
Shares outstanding: 139751234
Book value: 584615.384615384
P/B ratio: 11.70165834928231
Market cap (USD): 6840969.4965034975
Debt to equity: 40.28708133971296
Current ratio: 0.1755503144654088
Quick ratio: 0.10110062893081762
Interest coverage ratio: -0.11818095868393684
COGS to revenue (%): 40.62573040836088
SG&A to revenue (%): 17.97722795418879
Free cash flow (dilution-adjusted): -4641958.041958042
Buyback yield (%): 0
Retained earnings: -12758741.25874126
Inventory turnover: 4.282646955297431
Receivables turnover: 47.015698587127154
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.26618065898461
FCF margin (%): -22.164346054960102
Revenue growth (%): 25980.40638606676
Rule of 40 score: 25958.2420400118
Financial ratios for CEQ.V — quarterly report dated 2024-12-31
Total revenue: 3881818.181818182
Gross profit: 3374125.874125874
Operating income: 1348951.048951049
Net income: -3295104.8951048953
Capital expenditures: 2161538.4615384615
Operating cash flow: 331468.53146853147
Depreciation & amortization: -463636.36363636365
Net tangible assets: 584615.3846153846
Owner earnings: -5920279.720279721
Return on net tangible assets (%): -1012.6794258373205
Capex to operating income (%): 160.23846552617934
Buffett classification: The Gruesome
Stock price: 0.04895104895104896
Shares outstanding: 139751234
Book value: 584615.384615384
P/B ratio: 11.70165834928231
Market cap (USD): 6840969.4965034975
Debt to equity: 40.28708133971296
Current ratio: 0.1755503144654088
Quick ratio: 0.10110062893081762
Interest coverage ratio: 0.27502138579982893
COGS to revenue (%): 13.078724554134388
SG&A to revenue (%): 5.242298684921636
Free cash flow (dilution-adjusted): -1848951.048951049
Buyback yield (%): 0
Retained earnings: -12758741.25874126
Inventory turnover: 0.2555438225976769
Receivables turnover: 8.714285714285715
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.04036999294505
FCF margin (%): -47.63105746712304
Rule of 40 score: -47.63105746712304
Financial ratios for CEQ.V — quarterly report dated 2025-03-31
Total revenue: 10254545.454545455
Gross profit: 6355944.055944056
Operating income: 1225874.1258741259
Net income: -818881.118881119
Capital expenditures: 117482.51748251749
Operating cash flow: 161538.46153846153
Depreciation & amortization: 1338461.5384615385
Net tangible assets: 523076.9230769231
Owner earnings: 402097.902097902
Capex to operating income (%): 9.583571021106675
Buffett classification: The Great
Stock price: 0.04195804195804196
Shares outstanding: 139751234
Book value: 523076.92307692766
P/B ratio: 11.209992032085465
Market cap (USD): 5863688.13986014
Debt to equity: 34.05614973262002
Current ratio: 0.159831406150348
Quick ratio: 0.15425782658126055
Effective tax rate (%): 304.3630017452007
Interest coverage ratio: 1.1338939197930142
COGS to revenue (%): 38.01827605019094
SG&A to revenue (%): 8.094653573376979
Free cash flow (dilution-adjusted): -12587.41258741259
Buyback yield (%): 0
Retained earnings: -13577622.377622379
Inventory turnover: 27.7363184079602
Receivables turnover: 4.360392506690455
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.537336611880419
FCF margin (%): -0.12274959083469723
Revenue growth (%): 164.16861826697894
Rule of 40 score: 164.04586867614424
Financial ratios for CEQ.V — quarterly report dated 2025-06-30
Total revenue: 5508759.124087591
Gross profit: 3593430.6569343065
Operating income: 28467.15328467153
Net income: -902919.7080291971
Capital expenditures: 521167.88321167877
Operating cash flow: 119708.02919708028
Depreciation & amortization: 879562.0437956203
Net tangible assets: -609489.0510948905
Owner earnings: -544525.5474452556
Capex to operating income (%): 1830.7692307692307
Buffett classification: The Gruesome
Stock price: 0.0437956204379562
Shares outstanding: 139751234
Book value: -609489.0510948896
Market cap (USD): 6120491.999999999
Debt to equity: -28.416766467065905
Current ratio: 0.19261951355884818
Quick ratio: 0.18702823595191503
Interest coverage ratio: 0.022634939059779452
COGS to revenue (%): 34.768782297601696
SG&A to revenue (%): 20.81621836491321
Free cash flow (dilution-adjusted): -455474.4525547445
Buyback yield (%): 0
Retained earnings: -15076642.335766422
Inventory turnover: 14.577777777777778
Receivables turnover: 2.384518167456556
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.09969834858632855
FCF margin (%): -8.268186034185769
Revenue growth (%): -46.279831236734495
Rule of 40 score: -54.54801727092026
Financial ratios for CEQ.V — quarterly report dated 2025-09-30
Total revenue: 4974100.719424461
Gross profit: 2894244.604316547
Operating income: -325899.28057553957
Net income: -2705035.971223022
Capital expenditures: 559712.2302158274
Operating cash flow: 239568.34532374103
Depreciation & amortization: 764748.201438849
Net tangible assets: -3333093.5251798565
Owner earnings: -2500000.0000000005
Buffett classification: The Gruesome
Stock price: 0.06474820143884892
Shares outstanding: 139751234
Book value: -3333093.5251798555
Market cap (USD): 9048641.050359713
Debt to equity: -5.545219080509391
Current ratio: 0.1330887163296072
Quick ratio: 0.1272008419375942
Interest coverage ratio: -0.1296508299942759
COGS to revenue (%): 41.81371131038472
SG&A to revenue (%): 16.922186867225918
Free cash flow (dilution-adjusted): -382014.3884892087
Buyback yield (%): 0
Retained earnings: -17563309.35251799
Inventory turnover: 13.966183574879226
Receivables turnover: 4.2261613691931545
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2204321353521201
FCF margin (%): -7.680069424356378
Revenue growth (%): -9.705605066761464
Rule of 40 score: -17.385674491117843
Financial ratios for CEQ.V — quarterly report dated 2025-12-31
Total revenue: 3423357.6642335765
Gross profit: 2141605.8394160583
Operating income: -8029.19708029197
Net income: -6312408.759124087
Capital expenditures: 709489.0510948905
Operating cash flow: 3011678.8321167883
Depreciation & amortization: 554744.5255474452
Net tangible assets: -10189051.09489051
Owner earnings: -6467153.284671533
Buffett classification: The Gruesome
Stock price: 0.058394160583941604
Shares outstanding: 139751234
Book value: -10189051.094890513
Market cap (USD): 8160656
Debt to equity: -1.9973493803281033
Current ratio: 0.10865525397004167
Quick ratio: 0.08303299921162292
Interest coverage ratio: -0.003050471436494731
COGS to revenue (%): 37.44136460554371
SG&A to revenue (%): 16.162046908315563
Free cash flow (dilution-adjusted): 2193430.6569343065
Buyback yield (%): 0
Retained earnings: -24132846.715328466
Inventory turnover: 1.9296703296703297
Receivables turnover: 8.605504587155965
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.046317739694302924
FCF margin (%): 64.0724946695096
Revenue growth (%): -31.17635011158995
Rule of 40 score: 32.89614455791964
Financial ratios for CEQ.V — annual report dated 2025-12-31
Total revenue: 24682481.751824815
Gross profit: 15305839.416058393
Operating income: 969343.0656934306
Net income: -10815328.467153285
Capital expenditures: 1921167.8832116786
Operating cash flow: 3543065.6934306566
Depreciation & amortization: 3607299.2700729924
Net tangible assets: -10189051.09489051
Owner earnings: -9129197.08029197
Capex to operating income (%): 198.19277108433732
Buffett classification: The Gruesome
Stock price: 0.058394160583941604
Shares outstanding: 139751234
Book value: -10189051.094890513
Market cap (USD): 8160656
Debt to equity: -1.9973493803281033
Current ratio: 0.10865525397004167
Quick ratio: 0.08303299921162292
Interest coverage ratio: 0.12048630012701869
COGS to revenue (%): 37.98905811030608
SG&A to revenue (%): 13.857755433979005
Free cash flow (dilution-adjusted): 1337226.2773722627
Buyback yield (%): 0
Retained earnings: -24132846.715328466
Inventory turnover: 14.116483516483518
Receivables turnover: 62.04587155963303
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.591814392184935
FCF margin (%): 5.417714032234215
Revenue growth (%): 17.853513990816
Rule of 40 score: 23.271228023050217
Financial ratios for CINEVISTA.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.17473295529473823
Shares outstanding: 57436475
Market cap (USD): 10036045.01846235
Buyback yield (%): 0
Retained earnings: -8319636.027957273
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CINEVISTA.NS — annual report dated 2023-03-31
Total revenue: 97442.14372716201
Gross profit: -3470267.96589525
Operating income: -4712935.444579781
Net income: -3408587.088915956
Capital expenditures: 9939.098660170524
Operating cash flow: -399537.149817296
Depreciation & amortization: 14068.209500609015
Net tangible assets: 8456857.4908648
Owner earnings: -3404457.978075518
Return on net tangible assets (%): -40.25677365088692
Buffett classification: The Gruesome
Stock price: 0.146163215590743
Shares outstanding: 57436475
Book value: 10918221.68087698
P/B ratio: 0.7689072564721001
Market cap (USD): 8395099.87819732
Debt to equity: 0.8724422291289691
Current ratio: 2.8730921136450505
Quick ratio: 0.737202191361957
Interest coverage ratio: -5.323702205528267
COGS to revenue (%): 3661.3624999999997
SG&A to revenue (%): 76.97500000000001
Free cash flow (dilution-adjusted): -430316.6869671133
Buyback yield (%): 0
Retained earnings: -11092850.18270402
Inventory turnover: 1.7471875260966558
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -23.142184372153444
FCF margin (%): -441.6124999999999
Rule of 40 score: -441.6124999999999
Financial ratios for CINEVISTA.NS — annual report dated 2024-03-31
Total revenue: 52824.07962585442
Gross profit: -41048.08730063557
Operating income: -477035.61578126875
Net income: -899364.4321861134
Capital expenditures: 29152.176519966422
Operating cash flow: -1182491.9055042572
Depreciation & amortization: 11176.400047967381
Net tangible assets: 7338349.922053004
Owner earnings: -917340.2086581126
Return on net tangible assets (%): -12.500633226842284
Buffett classification: The Gruesome
Stock price: 0.21892994241842612
Shares outstanding: 57436475
Book value: 9849958.028540593
P/B ratio: 1.2766109386488895
Market cap (USD): 12574564.164467372
Debt to equity: 0.2938562530740649
Current ratio: 0.2834184771215147
Quick ratio: 0.052197923447826894
Interest coverage ratio: -1.3384475623296659
COGS to revenue (%): 177.70715096481268
SG&A to revenue (%): 163.76844494892165
Free cash flow (dilution-adjusted): -1301043.2905624176
Buyback yield (%): 0
Retained earnings: -11820613.982491905
Inventory turnover: 0.04669362824045906
Receivables turnover: 110.125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.760318899241792
FCF margin (%): -2462.973893303065
Revenue growth (%): -45.789288283966904
Rule of 40 score: -2508.763181587032
Financial ratios for CINEVISTA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 6850860.009555662
Buffett classification: The Gruesome
Stock price: 0.2571667462971811
Shares outstanding: 57436475
Book value: 9392200.191113234
P/B ratio: 1.5726614737732336
Market cap (USD): 14770751.394529385
Debt to equity: 0.34941721829037986
Current ratio: 0.2635408852213053
Quick ratio: 0.03064099358172875
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CINEVISTA.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.22053852430353188
Shares outstanding: 57436475
Market cap (USD): 12666955.4376967
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CINEVISTA.NS — quarterly report dated 2025-03-31
Total revenue: 1341384.1477671263
Gross profit: -1191512.7425765723
Operating income: -1775146.1304652793
Net income: -3023883.5632452653
Capital expenditures: 0
Depreciation & amortization: 7154.547580079495
Net tangible assets: 3462380.1730184704
Owner earnings: -3016729.0156651856
Return on net tangible assets (%): -87.12876301608526
Buffett classification: The Gruesome
Stock price: 0.1612790290582332
Shares outstanding: 57436475
Book value: 5906008.884732287
P/B ratio: 1.5684532653640562
Market cap (USD): 9263298.920527484
Debt to equity: 0.4960906571654791
Current ratio: 1.5866855608464931
Quick ratio: 0.05897338785978029
Interest coverage ratio: -16.442447211694642
COGS to revenue (%): 188.82710777221942
Buyback yield (%): 0
Retained earnings: -14819604.863221884
Inventory turnover: 0.20117269650558728
Receivables turnover: 2048.964285714286
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.220278337432543
Rule of 40 score: 0
Financial ratios for CINEVISTA.NS — annual report dated 2025-03-31
Total revenue: 1349485.6207622164
Gross profit: -1225613.7479541735
Operating income: -1701437.9237783493
Net income: -3696375.9644610705
Capital expenditures: 42027.12181435585
Operating cash flow: 297439.79424830485
Depreciation & amortization: 18365.676876315174
Net tangible assets: 3462380.1730184704
Owner earnings: -3720037.409399111
Return on net tangible assets (%): -107.44162176032846
Buffett classification: The Gruesome
Stock price: 0.1612790290582332
Shares outstanding: 57436475
Book value: 5906008.884732287
P/B ratio: 1.5684532653640562
Market cap (USD): 9263298.920527484
Debt to equity: 0.4960906571654791
Current ratio: 1.5866855608464931
Quick ratio: 0.05897338785978029
Interest coverage ratio: -3.9848045121016322
COGS to revenue (%): 190.82080824706546
SG&A to revenue (%): 10.354745094642007
Free cash flow (dilution-adjusted): 253039.51367781154
Buyback yield (%): 0
Retained earnings: -14819604.863221884
Inventory turnover: 0.20452458437983112
Receivables turnover: 2061.339285714286
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.38068523048529
FCF margin (%): 18.75081214536319
Revenue growth (%): 2454.678908407746
Rule of 40 score: 2473.4297205531093
Financial ratios for CINEVISTA.NS — quarterly report dated 2025-06-30
Total revenue: 541703.7210390826
Gross profit: 344874.7952258367
Operating income: 221811.3737421016
Net income: 116253.21787970982
Capital expenditures: 0
Depreciation & amortization: 5967.704189094314
Owner earnings: 122220.92206880412
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.22139012403463612
P/E ratio: 27.345196451937593
Shares outstanding: 57436475
Market cap (USD): 12715868.324362276
Effective tax rate (%): 0
Interest coverage ratio: 2.100155107467317
COGS to revenue (%): 36.335162224046314
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -59.61606360558197
Rule of 40 score: -59.61606360558197
Financial ratios for CINEVISTA.NS — quarterly report dated 2025-09-30
Total revenue: 427452.0856820744
Gross profit: 269413.75422773394
Operating income: 170067.64374295378
Net income: 86922.20969560316
Capital expenditures: 0
Depreciation & amortization: 5851.183765501691
Net tangible assets: 3494103.720405862
Owner earnings: 92773.39346110485
Return on net tangible assets (%): 2.6551413720005033
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.20450958286358512
P/E ratio: 33.783970703631645
Shares outstanding: 57436475
Book value: 5894532.130777903
P/B ratio: 1.9927467155657987
Market cap (USD): 11746309.543404736
Debt to equity: 0.43704922108846794
Current ratio: 1.5998765616707862
Quick ratio: 0.060597664347433355
Effective tax rate (%): 0
Interest coverage ratio: 2.0454237288135593
COGS to revenue (%): 36.972174601081356
Buyback yield (%): 0
Inventory turnover: 0.013350781351192787
Receivables turnover: 338.5267857142857
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0121623442191514
Revenue growth (%): -21.091166798310624
Rule of 40 score: -21.091166798310624
Financial ratios for CINEVISTA.NS — quarterly report dated 2025-12-31
Total revenue: 919505.4026957782
Gross profit: 577921.3545727972
Operating income: 460788.68218781333
Net income: 392068.61980617134
Capital expenditures: 0
Depreciation & amortization: 5837.139356132338
Owner earnings: 397905.7591623037
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.175002784894731
P/E ratio: 6.409300930858621
Shares outstanding: 57436475
Market cap (USD): 10051543.079536594
Effective tax rate (%): 0
Interest coverage ratio: 6.617341225403935
COGS to revenue (%): 37.14867222329909
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 115.11309302153639
Rule of 40 score: 115.11309302153639
Financial ratios for COTN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 353.35164835164835
Shares outstanding: 7770025
Market cap (USD): 2745551141.4835167
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COTN.SW — annual report dated 2022-12-31
Total revenue: 637385869.5652174
Gross profit: 284383695.6521739
Operating income: 107580434.78260869
Net income: 84901086.95652173
Capital expenditures: 22257608.695652172
Operating cash flow: 70007608.69565217
Depreciation & amortization: 21170652.173913043
Net tangible assets: 318073913.04347825
Owner earnings: 83814130.43478261
Return on net tangible assets (%): 26.35052011427478
Capex to operating income (%): 20.68927193000182
Buffett classification: The Great
Stock price: 206.34782608695653
P/E ratio: 18.884655366219
Shares outstanding: 7770025
Book value: 360360869.5652174
P/B ratio: 4.449228267557883
Market cap (USD): 1603327767.3913045
Debt to equity: 0.2951932241834876
Current ratio: 2.6934032280745615
Quick ratio: 1.7366369275480071
Effective tax rate (%): 18.09726533008976
Interest coverage ratio: 57.710787172011656
COGS to revenue (%): 55.38263457225931
R&D to revenue (%): 10.874240060027796
SG&A to revenue (%): 17.700014495348697
Free cash flow (dilution-adjusted): 43926086.956521735
Buyback yield (%): 0
Retained earnings: 385750000
Inventory turnover: 2.6518029199464355
Receivables turnover: 7.489367408712978
Capitalized R&D asset: 69310869.56521739
ROCI (R&D-adjusted, %): 28.7240601071263
FCF margin (%): 6.89160037176306
Rule of 40 score: 6.89160037176306
Financial ratios for COTN.SW — annual report dated 2023-12-31
Total revenue: 473158333.3333334
Gross profit: 193959523.80952382
Operating income: 29735714.285714287
Net income: 18319047.61904762
Capital expenditures: 27969047.61904762
Operating cash flow: 26496428.57142857
Depreciation & amortization: 23830952.38095238
Net tangible assets: 308972619.04761904
Owner earnings: 14180952.38095238
Return on net tangible assets (%): 4.589711678874303
Capex to operating income (%): 94.05877171911281
Buffett classification: The Gruesome
Stock price: 311.7857142857143
P/E ratio: 132.2439269235768
Shares outstanding: 7770025
Book value: 352490476.1904762
P/B ratio: 6.8727609915161505
Market cap (USD): 2422582794.642857
Debt to equity: 0.32258217040649534
Current ratio: 3.4014168559658104
Quick ratio: 2.074012756837228
Effective tax rate (%): 18.98494261345688
Interest coverage ratio: 11.281842818428183
COGS to revenue (%): 59.007480129726034
R&D to revenue (%): 15.275265251488854
SG&A to revenue (%): 21.406053042749708
Free cash flow (dilution-adjusted): -5696428.571428571
Buyback yield (%): 0.09577538899264536
Retained earnings: 398739285.71428573
Inventory turnover: 2.2674949241032585
Receivables turnover: 7.420844302544857
Capitalized R&D asset: 118714473.08488613
ROCI (R&D-adjusted, %): 9.29502634525133
Rosenberg metric: -1.304617477891636
FCF margin (%): -1.203915934714293
Revenue growth (%): -25.765794956187086
Rule of 40 score: -26.96971089090138
Financial ratios for COTN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 319932222.2222222
Buffett classification: The Gruesome
Stock price: 273.65555555555557
Shares outstanding: 7770025
Book value: 358997777.7777778
P/B ratio: 5.922907158973438
Market cap (USD): 2126310508.0555556
Debt to equity: 0.30211267169713213
Current ratio: 3.13782064068297
Quick ratio: 2.093140383771493
Buyback yield (%): 0
Retained earnings: 394740000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COTN.SW — annual report dated 2024-12-31
Total revenue: 494846666.6666666
Gross profit: 211923333.3333333
Operating income: 39845555.55555555
Net income: 36422222.222222224
Capital expenditures: 10247777.777777778
Operating cash flow: 55514444.44444444
Depreciation & amortization: 24560000
Net tangible assets: 319932222.2222222
Owner earnings: 50734444.44444445
Return on net tangible assets (%): 15.857872674420626
Capex to operating income (%): 25.718747385739388
Buffett classification: The Good
Stock price: 273.65555555555557
P/E ratio: 58.37948313758389
Shares outstanding: 7770025
Book value: 358997777.7777778
P/B ratio: 5.922907158973438
Market cap (USD): 2126310508.0555556
Debt to equity: 0.30211267169713213
Current ratio: 3.13782064068297
Quick ratio: 2.093140383771493
Effective tax rate (%): 13.433860617424143
Interest coverage ratio: 17.207773512476006
COGS to revenue (%): 57.17393940210436
R&D to revenue (%): 15.101872184874326
SG&A to revenue (%): 21.178277446212295
Free cash flow (dilution-adjusted): 40166666.666666664
Buyback yield (%): 0.06568498163252152
Retained earnings: 394740000
Inventory turnover: 2.430891281933784
Receivables turnover: 5.757973806353188
Capitalized R&D asset: 146028745.68668047
ROCI (R&D-adjusted, %): 6.821907573085843
Rosenberg metric: 0.24854394518381825
FCF margin (%): 8.116992469047652
Revenue growth (%): 4.583736944997253
Rule of 40 score: 12.700729414044904
Financial ratios for COTN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 342291250
Buffett classification: The Gruesome
Stock price: 311
Shares outstanding: 7770025
Book value: 385181250
P/B ratio: 6.273612163105032
Market cap (USD): 2416477775
Debt to equity: 0.3029645134595726
Current ratio: 1.896515684081589
Quick ratio: 1.2126138360760506
Buyback yield (%): 0
Retained earnings: 443513750
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRAV.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 82.92045454545455
Shares outstanding: 1198982
Market cap (USD): 99420132.43181819
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRAV.PA — annual report dated 2022-12-31
Total revenue: 525088297.87234044
Net income: 141385106.38297874
Capital expenditures: 30553191.489361703
Operating cash flow: -118108510.63829789
Depreciation & amortization: 22008510.638297874
Net tangible assets: 3769090425.531915
Owner earnings: 132840425.53191492
Return on net tangible assets (%): 3.5244690504650795
Buffett classification: The Gruesome
Stock price: 64.46808510638299
P/E ratio: 0.5467059126273495
Shares outstanding: 1198982
Book value: 3773897872.3404274
P/B ratio: 0.0204817608297082
Market cap (USD): 77296073.61702129
Debt to equity: 0.16946077535952436
Effective tax rate (%): 17.606725273090227
COGS to revenue (%): 0
SG&A to revenue (%): 18.317891823664915
Free cash flow (dilution-adjusted): -148661702.1276596
Buyback yield (%): 0
Retained earnings: 141385106.38297874
Receivables turnover: 1.5104998041423885
Capitalized R&D asset: 0
FCF margin (%): -28.31175303849606
Rule of 40 score: -28.31175303849606